| Basics |
Alkermes plc Ordinary Shares
Alkermes PLC is a fully integrated, biopharmaceutical company. It applies its scientific expertise and proprietary technologies to research, develop and commercialize pharmaceutical products to address unmet medical needs of patients.
|
| IPO Date: |
August 1, 1991 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$4.6B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.49 | 1.87%
|
| Avg Daily Range (30 D): |
$0.53 | 1.80%
|
| Avg Daily Range (90 D): |
$0.47 | 1.52%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.06M |
| Avg Daily Volume (30 D): |
1.51M |
| Avg Daily Volume (90 D): |
1.32M |
| Trade Size |
| Avg Trade Size (Sh.): |
120 |
| Avg Trade Size (Sh.) (30 D): |
60 |
| Avg Trade Size (Sh.) (90 D): |
62 |
| Institutional Trades |
| Total Inst.Trades: |
13,189 |
| Avg Inst. Trade: |
$2.48M |
| Avg Inst. Trade (30 D): |
$3.89M |
| Avg Inst. Trade (90 D): |
$3.82M |
| Avg Inst. Trade Volume: |
.09M |
| Avg Inst. Trades (Per Day): |
3 |
| Market Closing Trades |
| Avg Closing Trade: |
$5.09M |
| Avg Closing Trade (30 D): |
$9.56M |
| Avg Closing Trade (90 D): |
$10.58M |
| Avg Closing Volume: |
172.63K |
|
|
|
|
| Financials |
| |
TTM |
Q1 2025 |
Q4 2024 |
|
Basic EPS
|
$2.15
|
$.14
|
$-1.07
|
|
Diluted EPS
|
$2.08
|
$.13
|
$-1.07
|
|
Revenue
|
$ 1.51B
|
$ 306.51M
|
$ 2.12M
|
|
Gross Profit
|
$ 1.28B
|
$ 257.31M
|
$
|
|
Net Income / Loss
|
$ 352.71M
|
$ 22.46M
|
$ -57.96M
|
|
Operating Income / Loss
|
$ 391.12M
|
$ 13.79M
|
$ -64.9M
|
|
Cost of Revenue
|
$ 235.88M
|
$ 49.2M
|
$
|
|
Net Cash Flow
|
$ -20.95M
|
$ 108.66M
|
$ -47.87M
|
|
PE Ratio
|
14.49
|
|
|
|
